Auteurs
Analysis
RSA
Racine
Analysis
RSA
Exploration
Accueil
Racine
Racine

Le SIDA en Afrique subsaharienne (serveur d'exploration) - Analysis (RSA)

Index « Auteurs » - entrée « Janaki Amin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Jana Trifinopoulos < Janaki Amin < Janan Dietrich  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000481 (2017) Mark A. Boyd [Australie] ; Janaki Amin [Australie] ; Patrick W G. Mallon [Irlande (pays)] ; Nagalingeswaran Kumarasamy [Inde] ; Johan Lombaard [Afrique du Sud] ; Robin Wood [Afrique du Sud] ; Ploenchan Chetchotisakd [Thaïlande] ; Praphan Phanuphak [Thaïlande] ; Lerato Mohapi [Afrique du Sud] ; Iskandar Azwa [Malaisie] ; Waldo H. Belloso [Argentine] ; Jean-Michel Molina [France] ; Jennifer Hoy [Australie] ; Cecilia L. Moore [Australie] ; Sean Emery [Australie] ; David A. Cooper [Australie]Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Absorptiometry, Photon
1Adult
1Anti-HIV Agents (administration & dosage)
1Anti-HIV Agents (adverse effects)
1Anti-HIV Agents (therapeutic use)
1Antiretroviral Therapy, Highly Active
1Body Composition
1CD4 Lymphocyte Count
1Drug Therapy, Combination
1Emtricitabine (administration & dosage)
1Emtricitabine (adverse effects)
1Female
1HIV Infections (drug therapy)
1HIV Infections (metabolism)
1HIV Infections (virology)
1HIV Protease Inhibitors (administration & dosage)
1HIV Protease Inhibitors (adverse effects)
1HIV-1 (drug effects)
1HIV-Associated Lipodystrophy Syndrome (epidemiology)
1Humans
1International Cooperation
1Lamivudine (administration & dosage)
1Lamivudine (adverse effects)
1Lopinavir (administration & dosage)
1Lopinavir (adverse effects)
1Lopinavir (therapeutic use)
1Male
1Raltegravir Potassium (administration & dosage)
1Raltegravir Potassium (adverse effects)
1Raltegravir Potassium (therapeutic use)
1Reverse Transcriptase Inhibitors (administration & dosage)
1Reverse Transcriptase Inhibitors (adverse effects)
1Reverse Transcriptase Inhibitors (therapeutic use)
1Ritonavir (administration & dosage)
1Ritonavir (adverse effects)
1Ritonavir (therapeutic use)
1Tenofovir (administration & dosage)
1Tenofovir (adverse effects)
1Viral Load

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/RSA/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i -k "Janaki Amin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/RSA/Analysis/Author.i  \
                -Sk "Janaki Amin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/RSA/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    RSA
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Janaki Amin
}}
Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024